Curaxis Pharmaceutical (Curaxis Pharmaceutical) General and Admin. Expense : $1.89 Mil (TTM As of Dec. 2011)

View and export this data going back to . Start your Free Trial

What is Curaxis Pharmaceutical General and Admin. Expense?

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Curaxis Pharmaceutical's General and Admin. Expense for the six months ended in Dec. 2011 was $1.89 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2011 was $1.89 Mil.

Curaxis Pharmaceutical General and Admin. Expense Historical Data

The historical data trend for Curaxis Pharmaceutical's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curaxis Pharmaceutical General and Admin. Expense Chart

Curaxis Pharmaceutical Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

General and Admin. Expense

0.02

1.08

1.86

1.89

Curaxis Pharmaceutical Semi-Annual Data
	Dec08	Dec09	Dec10	Dec11
General and Admin. Expense	0.02	1.08	1.86	1.89

Curaxis Pharmaceutical General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2011 was $1.89 Mil.

Curaxis Pharmaceutical General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of Curaxis Pharmaceutical's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Curaxis Pharmaceutical (Curaxis Pharmaceutical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curaxis Pharmaceutical Corp (OTCPK:CURXQ) » Definitions » General and Admin. Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.curaxispharma.com

Curaxis Pharmaceutical Corp was incorporated in Delaware on February 27, 2001. It is a specialty pharmaceutical company with a hormone drug product candidate for the treatment of Alzheimer's disease. The Company's therapeutic platform is based on the hypothesis that diseases of aging may be caused by age-related changes in the function of the hypothalamic-pituitary-gonadal (HPG) axis. The HPG axis is a hormonal endocrine feedback loop that controls development, reproduction and aging in animals. This drug development platform is built on the premise that hormones associated with this feedback loop are beneficial early in life, when they promote growth and development, but are harmful later in life when the mechanism for feedback is compromised, thereby leading to disease processes, including pathologies associated with Alzheimer's disease and various cancers. Its discovery of similar hormonal signaling mechanisms at the cellular level in brain tissue from Alzheimer's patients and in multiple tumors will enable it to develop significant new treatments for Alzheimer's disease and may have applications for many cancers.

Executives

Timothy R Wright	director, officer: Chief Executive Officer	C/O CURAXIS, 1004 CHAGFORD WAY, RALEIGH NC 27614
Michael W George	director	C/O CURAXIS, 1004 CHAGFORD WAY, RALEIGH NC 27614

Curaxis Pharmaceutical (Curaxis Pharmaceutical) Headlines

No Headlines